chr3-69181308-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015123.3(FRMD4B):āc.2442G>Cā(p.Glu814Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000911 in 1,613,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015123.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FRMD4B | NM_015123.3 | c.2442G>C | p.Glu814Asp | missense_variant | 21/23 | ENST00000398540.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FRMD4B | ENST00000398540.8 | c.2442G>C | p.Glu814Asp | missense_variant | 21/23 | 1 | NM_015123.3 | P1 | |
FRMD4B | ENST00000478263.5 | c.1398G>C | p.Glu466Asp | missense_variant | 11/13 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000132 AC: 33AN: 249226Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135212
GnomAD4 exome AF: 0.0000889 AC: 130AN: 1461692Hom.: 0 Cov.: 37 AF XY: 0.0000770 AC XY: 56AN XY: 727120
GnomAD4 genome AF: 0.000112 AC: 17AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 09, 2022 | The c.2442G>C (p.E814D) alteration is located in exon 21 (coding exon 21) of the FRMD4B gene. This alteration results from a G to C substitution at nucleotide position 2442, causing the glutamic acid (E) at amino acid position 814 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at